ozempic novo nordisk - Search News

News

Novo Nordisk, compounders

Novo Nordisk expands lawsuits against weight-loss drug compounders

Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of unapproved versions of semaglutide, the main ingredient in its popular weight-loss and diabetes drugs,

MarketWatch on MSN · 13h

Novo Nordisk is no longer a buy at UBS, which says compounding is here to stay

Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to competition from compounding as well as arch rival Eli Lilly, a brokerage said on Tuesday.

CNBC on MSN · 3h

Novo Nordisk expands legal action to protect patients from non-FDA approved weight-loss drugs

CNBC's Brandon Gomez and Angelica Peebles join 'Power Lunch' to break down the biggest headlines in the pharmaceutical space.

Novo Nordisk Faces Ozempic-Linked Securities Fraud Claims

Levi & Korsinsky is representing the shareholder plaintiff in a suit claiming the Ozempic and Wegovy manufacturer withheld ...

5hon MSN

Why Novo Nordisk Stock Is Down Again Today

Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...

Fierce Pharma10h

Novo Nordisk faces investor lawsuit over 'false and misleading' semaglutide sales projections

Novo Nordisk underestimated the impact of competition from personalized compounded drugs when providing sales estimates for ...

Ozempic could be hurting your gym gains — with potentially dangerous consequences

Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...

6don MSN

Ozempic maker Novo Nordisk has its worst day since Black Monday

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

24/7 Wall St.7d

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

President Donald Trump says pharma tariffs could go as high as 250%. UBS downgrades Novo Nordisk stock to neutral and lowers ...

10h

Novo Nordisk to Disclose Full Second-Quarter Earnings Amid Management Reshuffle -- Earnings Preview

Novo Nordisk is scheduled to report results for the second quarter on Wednesday. Here is what you need to know: PROFIT FORECAST: The company pre-released preliminary second-quarter numbers last week, ...

Novo Nordisk: I Was Wrong Twice, But This Selloff Looks Like 2016 All Over Again

Novo Nordisk is attractively valued after the sell-off, but near-term recovery requires patience. Read why I'm downgrading ...

3 Minute Breakdowns on MSN3d

novo nordisk stock analysis: ozempic, wegovy, and market share - august 2025

Is Novo Nordisk stock a buy? An analysis of $NVO, its weight loss drugs Ozempic and Wegovy, and market share competition with ...

Wegovy maker Novo hit with investor class action over revenue forecast cut

Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...

Novo Nordisk: Is This An Overreaction Or The End Of The GLP-1 Fairy Tale?

Novo Nordisk faces slowing demand, rising competition, and CEO transition. Learn about challenges impacting its growth and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results